Towards human organ generation using interspecies blastocyst complementation: Challenges and perspectives for therapy

Area of Science:

• Developmental Biology
• Regenerative Medicine
• Transplantation Science

Background:

• Millions face end-stage refractory diseases, with organ transplantation being the ideal treatment.
• A critical shortage of donor organs leads to high mortality rates among patients awaiting transplants.
• Current technologies cannot achieve sustainable, patient-derived organ generation.

Purpose of the Study:

• To review emerging technologies for human organ generation.
• To assess the efficiency of chimera formation in human cells using blastocyst complementation (BC).
• To advance the field of human organ generation via BC and transplantation.

Main Methods:

• Review of current scientific literature on organ generation technologies.
• Analysis of developmental biology principles related to blastocyst complementation.
• Evaluation of chimera formation efficiency in human cells.

Main Results:

• Emerging technologies, particularly blastocyst complementation (BC), show promise for generating human organs.
• The efficiency of chimera formation in human cells is a critical factor for successful organ generation.
• Further research is needed to optimize BC for clinical application.

Conclusions:

• Human organ generation via blastocyst complementation is a promising avenue for addressing organ shortages.
• Understanding and improving chimera formation efficiency is key to advancing this technology.
• This review provides a foundation for future research and development in patient-derived organ generation.